epiglucan and Leukocyte-Disorders

epiglucan has been researched along with Leukocyte-Disorders* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Leukocyte-Disorders

ArticleYear
Limited role of the spleen in a mouse model of trained immunity: Impact on neutrophilia.
    Journal of leukocyte biology, 2022, Volume: 111, Issue:1

    Trained immunity is a de facto memory of innate immune cells, resulting in a long-term increase in innate host defense mechanisms after infection. The long-term heterologous protection conferred by trained immunity is mediated through epigenetic and functional reprogramming of hematopoietic stem and progenitor cells. Because the spleen is a reservoir of undifferentiated monocytes and is considered the prime organ for extramedullary hematopoiesis, we investigated the role of the spleen in the establishment of trained immunity. A β-glucan-induced trained immunity mouse model was performed in previously sham-operated or splenectomized animals. Removal of the spleen did not modulate the proinflammatory cytokine production of in vivo trained peritoneal cells, nor did it ablate the increased percentage of proinflammatory circulatory monocytes and natural killer cells seen in trained animals. However, spleen removal prevented neutrophilia, an important characteristic of trained immunity. These data point to a limited role of the spleen in trained immunity. The pathophysiologic relevance of the spleen in the induction of neutrophilia during trained immunity remains to be fully explored.

    Topics: Animals; beta-Glucans; Cells, Cultured; Female; Immunity, Innate; Inflammation; Leukocyte Disorders; Mice; Mice, Inbred C57BL; Neutrophils; Spleen

2022